down arrow

Godavari Drugs

14
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE362C01012
  • NSEID:
  • BSEID: 530317
INR
93.00
1.7 (1.86%)
BSENSE

Apr 11, 12:42 PM

BSE+NSE Vol: 388

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is -1.82% vs -0.92% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 34.11% vs -12.13% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 25.15% vs 37.83% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 46.57% vs -27.82% in Mar 2023

Compare Profit and Loss Results of Godavari Drugs
Markets Mojo
Figures in Rs cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
156.00
9,264.00
-9,108.00
-98.32%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
156.00
9,264.00
-9,108.00
-98.32%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-25.00
24.00
96.00%
Raw Materials Consumed
121.00
2,933.00
-2,812.00
-95.87%
Power & Fuel Cost
8.00
70.00
-62.00
-88.57%
Employee Cost
5.00
1,982.00
-1,977.00
-99.75%
Operating Expenses
3.00
143.00
-140.00
-97.90%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
806.00
-806.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
136.00
-132.00
-97.06%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
143.00
6,939.00
-6,796.00
-97.94%
Operating Profit (PBDIT) excl Other Income
13.00
2,325.00
-2,312.00
-99.44%
Other Income
0.00
266.00
-266.00
-100.00%
Operating Profit (PBDIT)
13.00
2,592.00
-2,579.00
-99.50%
Interest
4.00
15.00
-11.00
-73.33%
Profit before Depriciation and Tax
9.00
2,577.00
-2,568.00
-99.65%
Depreciation
1.00
317.00
-316.00
-99.68%
Profit Before Taxation & Exceptional Items
7.00
2,259.00
-2,252.00
-99.69%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
2,259.00
-2,253.00
-99.73%
Provision for Tax
1.00
436.00
-435.00
-99.77%
Profit After Tax
5.00
1,823.00
-1,818.00
-99.73%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
7,868.00
-7,854.00
-99.82%
Profit Available for appropriations
20.00
9,691.00
-9,671.00
-99.79%
Appropriations
20.00
9,691.00
-9,671.00
-99.79%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
7.37
45.52
-38.15
-83.81%
Profit And Loss - Net Sales
Net Sales 156.71 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -1.82% vs -0.92% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.30 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 34.11% vs -12.13% in Mar 2023

Profit And Loss - Interest
Interest 4.92 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 25.15% vs 37.83% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 5.55 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 46.57% vs -27.82% in Mar 2023